Prelude Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-655
| Closed | -$54K | – | 1594 |
|
|
2020
Q1 | $54K | Sell |
655
-10,800
| -94% | -$890K | ﹤0.01% | 466 |
|
|
2019
Q4 | $1.09M | Buy |
+11,455
| New | +$1.09M | 0.04% | 178 |
|
|
2019
Q3 | – | Sell |
-29,656
| Closed | -$2.71M | – | 1453 |
|
|
2019
Q2 | $2.71M | Buy |
29,656
+9,637
| +48% | +$880K | 0.13% | 69 |
|
|
2019
Q1 | $1.73M | Buy |
20,019
+1,641
| +9% | +$141K | 0.1% | 96 |
|
|
2018
Q4 | $1.41M | Buy |
18,378
+15,010
| +446% | +$1.15M | 0.09% | 149 |
|
|
2018
Q3 | $260K | Sell |
3,368
-14,741
| -81% | -$1.14M | 0.02% | 481 |
|
|
2018
Q2 | $1.23M | Buy |
18,109
+4,239
| +31% | +$287K | 0.08% | 201 |
|
|
2018
Q1 | $1.01M | Buy |
+13,870
| New | +$1.01M | 0.07% | 240 |
|
|
2017
Q4 | – | Sell |
-7,867
| Closed | -$605K | – | 1456 |
|
|
2017
Q3 | $605K | Buy |
7,867
+7,777
| +8,641% | +$598K | 0.05% | 293 |
|
|
2017
Q2 | $7K | Buy |
+90
| New | +$7K | ﹤0.01% | 1319 |
|
|
2015
Q3 | – | Sell |
-5,345
| Closed | -$471K | – | 1604 |
|
|
2015
Q2 | $471K | Hold |
5,345
| – | – | 0.07% | 300 |
|
|
2015
Q1 | $472K | Buy |
+5,345
| New | +$472K | 0.07% | 348 |
|